MedGenome has recently acquired a stake in GenX Diagnostics, a well-established diagnostics chain located in Odisha. This partnership is set to introduce advanced genomic solutions to the region, promising to enhance diagnostic and healthcare outcomes for the local population.
GenX Diagnostics, renowned for its strong regional presence, currently operates seven diagnostic centers and 60 collection centers throughout Odisha. Their flagship laboratory, located in Saheed Nagar, Bhubaneswar, holds accreditations from both the National Accreditation Board for Testing and Calibration Laboratories (NABL) and the National Accreditation Board for Hospitals & Healthcare Providers (NABH). Through this strategic collaboration, GenX Diagnostics aims to harness MedGenome’s advanced scientific and technological capabilities to deliver actionable genetic insights. This will enable clinicians to offer more precise and targeted treatments to their patients.
Dr. Vedam Ramprasad, CEO of MedGenome, expressed his excitement about the acquisition, highlighting its potential to expand MedGenome’s market presence and product portfolio. He emphasized that GenX Diagnostics aligns perfectly with MedGenome’s mission to leverage genomics in addressing healthcare challenges. The acquisition aims to bolster MedGenome’s network in tier II and tier III cities across India, driving deeper market penetration and introducing innovative new tests.
Dr. Biswajit Mohanty, Managing Director & Chairman of GenX Diagnostics, Bhubaneswar, echoed these sentiments, emphasizing their commitment to enhancing healthcare services in Odisha through this collaboration. He noted that combining GenX Diagnostics’ extensive product range with MedGenome’s omics solutions will empower healthcare providers and consumers in Eastern India with state-of-the-art diagnostic capabilities.
